logo
Select company
Select metric
Ticker Information

Ticker

XNCR

Company Name

XENCOR INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

XENCOR INC - Enterprise Value over EBIT Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

XNCR - EV/EBIT Historical data
DateEarning Before Interest & Taxes (EBIT)Enterprise ValueEnterprise Value over EBIT
6/30/2025$ -134.76M$ 702.43M0
3/31/2025$ -169.98M$ 750.54M0
12/31/2024$ -194.36M$ 1.25B0
9/30/2024$ -190.67M$ 1.64B0
6/30/2024$ -170.59M$ 1.16B0
3/31/2024$ -127.55M$ 1.51B0
12/31/2023$ -120.28M$ 1.43B0
9/30/2023$ -119.44M$ 1.06B0
6/30/2023$ -126.84M$ 1.44B0
3/31/2023$ -138.87M$ 1.64B0
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • XENCOR INC's latest trailing twelve months (TTM) EV/EBIT stands at 0.
  • Over the past 5 years, XENCOR INC's average EV/EBIT has been 47.49.
  • The median EV/EBIT for XENCOR INC during this period was 51.79
  • XENCOR INC reached its highest EV/EBIT over the past 5 years at 78.15.
  • The lowest EV/EBIT recorded by XENCOR INC in the same timeframe 13.16

XENCOR INC's EV/EBIT vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EV/EBIT Benchmarks
CompanyEV/EBIT
RGNX : REGENXBIO INC -ANAB : ANAPTYSBIO INC -CTMX : CYTOMX THERAPEUTICS INC 6.29KURA : KURA ONCOLOGY INC -PHAT : PHATHOM PHARMACEUTICALS INC -MRVI : MARAVAI LIFESCIENCES HOLDINGS INC -SAGE : SAGE THERAPEUTICS INC -GYRE : GYRE THERAPEUTICS INC 91.92ARCT : ARCTURUS THERAPEUTICS HOLDINGS INC -DAWN : DAY ONE BIOPHARMACEUTICALS INC -

Definition of Enterprise Value over EBIT

[Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest and taxes [EBIT].
EV / EBIT
(=) EV/EBIT
EV/EBIT for XENCOR INC is calculated as follows: EV [ $ 2.13B ] / EBIT [ $ -82.84M ]
(=) EV/EBIT [ 0 ]

XNCR - Enterprise Value over EBIT, Last 5 years

13.16

Minimum

Mar 31, 2022

78.15

Maximum

Jun 30, 2022

47.49

Average

51.79

Median

EV/EBIT Benchmark Analysis

The chart above depicts the distribution of EV/EBIT for companies in the Total Stock Market. The average EV/EBIT of the companies is 19.91 with a standard deviation of 12.32.
The following table provides additional summary stats:
EV/EBIT in the Market:
filtered constituents2.25K
min0.05
max62.03
average19.91
median16.78
std12.32